|

GL0034 Dose Level 5 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Pharmaceutical Industries Limited1

Indications

  • Type II Diabetes Mellitus1
  • Diabetes1

Little Rock, Arkansas1 trial

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Lynn Institute of the Ozarks

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.